Henry Schein Inc (HSIC)
Health Services • Health Care
August 04, 2026 Henry Schein Inc. Reports Strong Q2 2026 Financial Results Amid Leadership Transition Henry Schein Inc. has reported a robust financial performance for Q2 2026, with a 6.7% increase in net sales and new leadership under CEO Frederick M. Lowery. The company navigates economic challenges while focusing on strategic growth and operational efficiency.
July 30, 2026 Henry Schein Announces Leadership Transitions: A Strategic Shift for Future Growth Henry Schein has revealed a strategic leadership restructuring to improve operational efficiency and customer focus. Key executives are transitioning out, but their expertise will remain vital as the company aims for future growth in the healthcare sector.
July 21, 2026 Henry Schein Set to Announce Q2 2026 Financial Results Henry Schein, Inc. will release its Q2 2026 financial results on August 4, featuring a live webcast with key executives. This event is crucial for investors seeking insights into the company's performance and future strategies.
May 22, 2026 Henry Schein Elects William K. “Dan” Daniel as Independent Chairman of the Board Henry Schein has elected William K. 'Dan' Daniel as the new Independent Chairman of the Board, succeeding Stanley M. Bergman. Daniel's extensive experience in healthcare leadership positions him well to guide the company as it aims for continued growth and innovation in the healthcare sector.
May 05, 2026 Henry Schein Reports Strong First Quarter 2026 Financial Results Henry Schein, Inc. reported robust financial results for Q1 2026, with total net sales of $3.4 billion, a 6.3% increase from the previous year. The CEO highlighted ongoing growth strategies and reaffirmed the company's financial outlook, demonstrating commitment to shareholder value and operational efficiency.
May 05, 2026 Henry Schein Inc. Reports Strong Q1 2026 Results Amid Leadership Transition Henry Schein Inc. reported robust Q1 2026 results, with net sales reaching $3.368 billion, driven by strategic acquisitions and strong demand. The appointment of Frederick M. Lowery as CEO marks a new chapter for the company as it navigates market challenges and focuses on operational excellence.
May 04, 2026 Henry Schein Inc. Announces Participation in May Investor Conferences Henry Schein, Inc. will participate in the Bank of America and Stifel Jaws & Paws investor conferences in May 2026. These presentations aim to enhance shareholder engagement and provide vital insights into the company's strategic direction.
April 30, 2026 Henry Schein Inc. Unveils Next Generation Clinical Workflow in Partnership with AWS Henry Schein One has launched its Next Generation Clinical Workflow, integrating AI and voice technology into the Dentrix Ascend platform. This innovation aims to streamline dental practices, enhance clinical decision-making, and improve patient engagement. Future updates promise further advancements in AI capabilities for a more efficient dental care experience.
April 28, 2026 Henry Schein Inc Unveils Groundbreaking AI Integration in Dentrix Ascend Henry Schein One has launched the Model Context Protocol (MCP) layer in Dentrix Ascend, revolutionizing dental practices with AI-driven workflows. This new feature allows for easy querying of data, automation of tasks, and customization of workflows, promising improved efficiency and patient care.
April 21, 2026 Henry Schein Inc. Set to Announce First Quarter 2026 Financial Results Henry Schein, Inc. will announce its first quarter 2026 financial results on May 5, 2026. The live conference call will feature key executives discussing the company's performance and strategies, highlighting its leadership in healthcare solutions.
April 08, 2026 Henry Schein Inc. Announces Board Restructuring in Transition of Leadership Henry Schein, Inc. is restructuring its Board of Directors as Stanley M. Bergman retires after 44 years. The board will reduce from 15 to 10 members, enhancing governance as Fred Lowery takes the lead.
March 10, 2026 Henry Schein One Launches Enhanced Dentrix Ascend: A Game Changer for Dental Practices Henry Schein One launched an enhanced Dentrix Ascend, offering innovative features like AI-driven tools and flexible packages to streamline operations for dental practices. This upgrade aims to improve efficiency and patient care, supporting practices as they grow and adapt to modern demands.
March 03, 2026 Henry Schein Inc. Announces Participation in Key Investor Conferences Henry Schein, Inc. will participate in two prominent investor conferences in March 2026, offering insights into its healthcare solutions. The events will be accessible via live webcast, ensuring broad engagement from investors and stakeholders.
February 24, 2026 Henry Schein Inc. Releases Strong Fourth Quarter and Full Year 2025 Financial Results Henry Schein, Inc. reported a strong fourth quarter for 2025, achieving $3.4 billion in sales, a 7.7% increase from 2024. The full-year results also showed growth, with total sales reaching $13.2 billion. The company is well-positioned for 2026 with a strategic focus on continued growth.
February 24, 2026 Henry Schein Inc. Reports Strong Financial Performance in 2025 Despite Market Challenges Henry Schein Inc. reported a net sales increase of 4.0% for 2025, reaching $13.184 billion, despite facing leadership changes and market challenges. The company continues to focus on innovation and operational efficiency, positioning itself for future growth.
February 19, 2026 Henry Schein One Unveils AI-Driven Image Verify to Revolutionize Dental Claims Management Henry Schein One has launched Image Verify, an AI-driven tool to streamline dental claims management by ensuring high-quality image submission. This innovation aims to reduce claim denials and enhance operational efficiency in dental practices.
February 17, 2026 Henry Schein One Elevates Dental Practices with New Integration of iTero Scanners Henry Schein One has announced a groundbreaking integration of iTero scanners with its practice management platforms, enhancing digital dentistry. This integration streamlines operations, improves patient care, and allows dental professionals to work more efficiently. The system is already being implemented in various markets, reinforcing a robust digital ecosystem in oral healthcare.
February 06, 2026 Henry Schein Inc. Supports 24 Years of Give Kids A Smile Program Henry Schein Inc. celebrates the 24th anniversary of the Give Kids A Smile program, providing essential dental care to underserved children across the U.S. The initiative will mobilize 325,000 children for free dental services in 2026, demonstrating the importance of oral health access.
January 22, 2026 Henry Schein to Host Fourth Quarter 2025 Earnings Call Henry Schein, Inc. will release its Q4 2025 financial results on February 24, 2026, followed by a live earnings call. Key executives will discuss the company's performance and strategic direction. The event highlights Henry Schein's strong market presence and commitment to healthcare innovation.
January 12, 2026 Henry Schein Inc. Appoints Frederick M. Lowery as New CEO Henry Schein, Inc. announces Frederick M. Lowery as its new CEO, succeeding Stanley M. Bergman. Lowery brings over 20 years of healthcare experience and aims to accelerate the company's strategic growth.
December 29, 2025 Henry Schein Inc. to Present at J.P. Morgan Healthcare Investor Conference Henry Schein, Inc. will present at the J.P. Morgan Healthcare Investor Conference on January 13, 2026. The company aims to showcase its growth and healthcare solutions for investors.
December 23, 2025 Henry Schein's CEO Search Process Nears Completion Henry Schein, the largest provider of healthcare solutions, is nearing the completion of its CEO search, expected to conclude by mid-January 2026. Interim CEO Stanley Bergman continues to lead the company through this transition, ensuring stability and momentum in its operations.
December 01, 2025 Henry Schein Expands Partnership with vVARDIS: A Game-Changer in Dental Care Henry Schein expands its partnership with vVARDIS to distribute the innovative Curodont™ product across the U.S., revolutionizing early-stage cavity treatment. This collaboration aims to enhance dental care efficiency while addressing significant health risks associated with untreated cavities.
November 25, 2025 Henry Schein One Launches Groundbreaking AI-Integrated Solutions at the Greater New York Dental Meeting Henry Schein One launched groundbreaking AI-integrated solutions at the Greater New York Dental Meeting, aiming to revolutionize dental practice management. Key features include Voice Notes for claims processing and Detect AI for enhanced diagnostic accuracy, improving efficiency and patient care.
November 13, 2025 Henry Schein Inc. to Present at Piper Sandler’s Healthcare Conference Henry Schein, Inc. will participate in the Piper Sandler Healthcare Conference on December 2, 2025, offering a live webcast of its presentation. The company, a leader in healthcare solutions, serves a diverse clientele and continues to demonstrate significant growth in the industry.
November 04, 2025 Henry Schein Reports Record Third Quarter 2025 Financial Results and Raises Full Year Non-GAAP EPS Guidance Henry Schein, Inc. reported a record $3.3 billion in net sales for Q3 2025, reflecting a 5.2% increase year-over-year. The company raised its full-year EPS guidance and demonstrated growth across all segments, highlighting a successful recovery strategy post-cyber incident.
November 04, 2025 Henry Schein Inc. Reports Strong Q3 2025 Results Amid Market Challenges Henry Schein Inc. reported a 5.2% increase in net sales for Q3 2025, driven by strong performance in its Global Distribution segment. Despite facing challenges like a cyber incident and new tariffs, the company remains well-positioned for future growth through strategic acquisitions and operational efficiencies.
November 03, 2025 Henry Schein Inc. Partners with AWS to Revolutionize Dentistry Through Generative AI Henry Schein Inc. has partnered with AWS to integrate generative AI into dental technology, aiming to streamline processes and improve patient care. This collaboration introduces innovative tools for operational efficiency and aims for global scalability while ensuring data privacy.
October 22, 2025 Henry Schein Inc. Announces Participation in November Investor Conferences Henry Schein, Inc. will present at two major investor conferences in November, sharing insights into its strategic initiatives and market outlook. Investors can access live webcasts of the presentations on the company's investor relations page.
October 21, 2025 Henry Schein Inc. to Host Third Quarter 2025 Earnings Call Henry Schein, Inc. is set to announce its Q3 2025 financial results on November 4, which will be followed by a live earnings call at 8:00 a.m. ET. This event is crucial for investors seeking insights into the company’s performance and future strategies.
August 05, 2025 Henry Schein Inc. Reports Q2 2025 Financial Results: Resilience Amid Economic Challenges Henry Schein Inc. reported a 3.3% increase in Q2 2025 net sales to $3.24 billion, despite a decline in net income due to rising operational costs. The company’s restructuring initiatives and strong equity position aim to enhance long-term efficiency and profitability amid economic challenges.
May 15, 2025 Henry Schein Inc. Set to Present at Jefferies Global Healthcare Conference Henry Schein, Inc. will present at the Jefferies Global Healthcare Conference on June 4, 2025. The event will offer insights into the company's growth and healthcare solutions, with a live webcast available for stakeholders.
May 06, 2025 Henry Schein Inc. Set to Present at Key Investor Conferences This May Henry Schein, Inc. will present at the Bank of America Healthcare Conference and the Stifel Jaws & Paws Conference in May 2025, highlighting its commitment to healthcare innovation. These events provide a platform for the company to engage with investors and share insights on its strategic direction and robust growth.
May 05, 2025 Henry Schein Reports Steady Financial Growth in First Quarter 2025 Henry Schein, Inc. announced its Q1 2025 financial results, showcasing a resilient business model with a slight sales increase despite currency challenges. The company aims for enhanced operational efficiency and customer experience through strategic initiatives.
May 05, 2025 Henry Schein Inc. Reports Q1 2025 Results: A Mixed Bag Amid Economic Pressures Henry Schein Inc. reported Q1 2025 net sales of $3.168 billion, a slight decline year-over-year due to mixed segment performances. The company is focusing on strategic restructuring and recovery from a cyber incident while maintaining shareholder value through share repurchase programs.
April 22, 2025 Henry Schein Medical Celebrates Emerging Talent with 2025 Rising Star Award Ian Jeffer, Head Athletic Trainer at Desert Ridge High School, was awarded the 2025 Rising Star Award by Henry Schein Medical for his dedication to student-athletes and mentorship. This award celebrates emerging talent in athletic training, highlighting Jeffer's impactful contributions and commitment to the profession.
April 08, 2025 Henry Schein Inc. Prepares for First Quarter 2025 Financial Results Release Henry Schein, Inc. is set to release its Q1 2025 financial results on May 5, 2025. A live webcast featuring key executives will provide insights into the company's performance and future strategies.
April 07, 2025 Henry Schein Sets Ambitious Net-Zero Targets with SBTi Validation Henry Schein has set validated net-zero emissions targets for 2050, approved by SBTi. The company aims to reduce greenhouse gas emissions and transition to 100% renewable electricity by 2030, showcasing its commitment to sustainability in healthcare.
March 25, 2025 Henry Schein Showcases Innovations and Insights at the 2025 International Dental Show Henry Schein, Inc. is set to showcase its latest innovations at the 2025 International Dental Show in Cologne. Highlights include discussions on digital dentistry, the launch of an integrated electronic health records project, and a variety of products aimed at enhancing practice efficiency and patient care.
March 12, 2025 Henry Schein Inc. Donates Health Care Products for Special Olympics World Winter Games 2025 Henry Schein Inc. is donating essential health care products for the Special Olympics World Winter Games 2025 in Turin, Italy, supporting the Healthy Athletes program. This initiative aims to provide free health screenings and education, addressing health disparities faced by athletes with intellectual and developmental disabilities.
March 11, 2025 Henry Schein Inc. Honored as One of the World’s Most Ethical Companies for 14th Consecutive Year Henry Schein, Inc. has been recognized as one of the World’s Most Ethical Companies for the 14th consecutive year, showcasing its long-standing commitment to ethical practices and corporate citizenship. The company’s initiatives in health care support, disaster relief, and public health awareness underscore its leadership in the healthcare sector.
March 03, 2025 Henry Schein to Showcase Healthcare Solutions at Upcoming Investor Conference Henry Schein, Inc. will present its healthcare solutions at the Leerink Global Healthcare Conference on March 11, 2025. The event will highlight the company's commitment to enhancing operational success for healthcare professionals, with a live webcast option for those unable to attend.
February 26, 2025 SWOT Analysis of Henry Schein Inc. in 2025 This SWOT analysis of Henry Schein Inc. in 2025 outlines the company's market leadership in healthcare, its operational strengths, and challenges such as reliance on suppliers and legal issues. It also identifies growth opportunities in emerging markets and the need for innovation amidst competitive threats.
February 26, 2025 Henry Schein Inc. Announces Nominations for 2025 Rising Star Award Henry Schein Medical has opened nominations for the 2025 Rising Star Award, highlighting emerging athletic trainers. Nominations are accepted until March 5, 2025, with public voting to follow for finalists announced on March 11.
February 25, 2025 Henry Schein Inc. Reports Strong Performance in 2024 Annual Report Henry Schein Inc. reports a 2.7% increase in revenue for 2024, reaching $12.67 billion. The company focuses on strategic growth despite challenges, including a cyber incident and restructuring costs.
February 25, 2025 Henry Schein Reports Strong Financial Performance and Strategic Developments in 2024 Henry Schein reported significant financial performance in Q4 2024, with $3.2 billion in net sales and a robust net income increase. The company's updated BOLD+1 Strategic Plan aims for continued growth despite market challenges, supported by a new organizational structure and shareholder initiatives.
February 12, 2025 Stanley M. Bergman Honored with NAW Lifetime Achievement Award Stanley M. Bergman, Chairman and CEO of Henry Schein, Inc., was honored with the NAW Dirk Van Dongen Lifetime Achievement Award for his leadership in wholesale distribution. The award highlights his commitment to health care professionals and the importance of collaboration within the industry.
February 10, 2025 Henry Schein Partners with ADA Foundation to Launch 23rd Year of Give Kids A Smile Program Henry Schein Inc. announces its support for the 23rd year of the Give Kids A Smile program, aiming to provide free dental care to 325,500 underserved children. With nearly 1,100 events planned, this initiative showcases the commitment to improving oral health among children in need across the U.S.
February 05, 2025 Henry Schein Inc. Celebrates Women Athletic Trainers on National Girls and Women in Sports Day Henry Schein Medical celebrated National Girls and Women in Sports Day by honoring women athletic trainers and highlighting their contributions in a new video featuring notable professionals from the WNBA. The initiative emphasizes the importance of supporting women in athletic training and promoting their impact in sports.
November 05, 2024 Henry Schein Inc. Reports Mixed Results for Q3 2024 amid Cyber Challenges Henry Schein Inc. reported mixed Q3 2024 results, with net sales increasing slightly but significant declines in net and operating income due to a cyber incident. The company is restructuring to enhance efficiencies while navigating a complex healthcare landscape.
August 06, 2024 Henry Schein Inc. Q2 2024 Financial Report: A Mixed Bag Amid Challenges Henry Schein Inc. reported a mixed Q2 2024 financial performance with a slight revenue increase but a decline in net income, impacted by operational challenges and a cyber incident. The company is focusing on strategic acquisitions and restructuring to enhance efficiency and recover its dental segment.
May 07, 2024 Henry Schein Inc. Q1 2024 Report: A Resilient Performance Amidst Challenges Henry Schein Inc. reported a 3.7% increase in Q1 2024 net sales, reaching $3.172 billion, but faced a 23.4% decline in net income. The company navigates challenges from cyber incidents and evolving market conditions while focusing on strategic growth initiatives.